Home|18th Symposium|Live Broadcast|Q & A Online|Feedback Survery|Previous Symposia

Time: Nov.26, 2014 (9:30-11:00am)

Venue:Lecture Hall, Science Building, Shantou University, Shantou, Guangdong, China

Format: The symposium will be live broadcasted via the internet to the whole country through the dominant education and health websites in China.

Honorary Supporters
Ministry of Education, PRC
National Health and Family Planning Commission, PRC

Sponsor
International Visiting Doctors Program of Li Ka Shing Foundation

Organizers
Li Ka Shing Foundation
China Education Television

Local Organizers
Shantou University [Introduction]
Shantou University Medical College[Introduction]
The National Institutes of Health, U.S.A [Introduction]

Link
www.cetv.edu.cn
www.centv.cn
www.edu.cn
www.cer.net
www.stu.edu.cn
www.med.stu.edu.cn
www.lksf.org
www.eol.cn

Windows Media Player
Tom - Skype

Dr. Zhengping Zhuang is a clinical pathologist, researcher, inventor and educator. He is the head of Molecular Pathogenesis Unit at Surgical Neurology Branch (SNB), NINDS, National Institutes of Health, USA.

Dr. Zhuang obtained his medical degree from Shanghai Second Medical University, China in 1983 and Ph.D in Molecular Biology & Pharmacology at Wayne State University, USA in 1990. He then received postgraduate and residency training at Harvard University Medical School, University of Michigan and National Cancer Institute (NCI) of the National Institute of Health. He became staff pathologist in NCI in 1996 before taking the Directorship of Molecular Pathogenesis Unit at National Institute of Neurological Disorders and Stroke (NINDS) since 1999.

Dr. Zhuang has received more than 20 awards for his outstanding research including numerous ones from the NIH, the Federal Laboratory Consortium award in 2010 for Excellence in Technology Transfer and Cy Katzer Humanitarian award this year for identification of a new syndrome of paraganglioma, somatostatinoma and polycythemia.

Dr. Zhuang has published more than 270 papers in various journals, including high impact ones such as Nature Genetics, New England Journal of Medicine, Science, Lancet and PNAS.